Skip to main content
. 2016 Jul 21;16(Suppl 2):87. doi: 10.1186/s12911-016-0314-3

Fig. 6.

Fig. 6

Tumour volume time evolution for a tumour treated with bevacizumab according to a treatment scheme consisting of the administration of 15 mg/kg of bevacizumab as a single-agent, once every three weeks for a total of 4 doses (blue line) and a fractionated version of the aforementioned treatment scheme consisting of the administration of 10 mg/kg of bevacizumab as a single-agent, every other week for a total of 6 doses (green line)